IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 175 filers reported holding IMMUNOMEDICS INC in Q1 2018. The put-call ratio across all filers is 0.81 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $20,892,000 | +494.5% | 245,698 | +147.8% | 2.26% | +216.7% |
| Q2 2020 | $3,514,000 | +6.0% | 99,149 | -59.7% | 0.71% | +10.5% |
| Q1 2020 | $3,314,000 | -33.0% | 245,822 | +5.2% | 0.64% | +26.7% |
| Q4 2019 | $4,944,000 | +5.1% | 233,645 | -34.2% | 0.51% | +28.5% |
| Q3 2019 | $4,705,000 | +7.7% | 354,816 | +12.7% | 0.40% | -1.2% |
| Q2 2019 | $4,368,000 | -8.3% | 314,912 | +27.0% | 0.40% | -5.6% |
| Q1 2019 | $4,765,000 | +9.9% | 248,031 | -18.4% | 0.42% | -8.8% |
| Q4 2018 | $4,335,000 | -24.8% | 303,790 | +9.8% | 0.47% | +0.9% |
| Q3 2018 | $5,762,000 | -26.9% | 276,634 | -16.9% | 0.46% | -16.6% |
| Q2 2018 | $7,877,000 | +77.8% | 332,771 | +9.7% | 0.55% | +74.8% |
| Q1 2018 | $4,431,000 | -56.4% | 303,301 | -51.8% | 0.32% | -5.4% |
| Q4 2017 | $10,160,000 | +117.4% | 628,750 | +88.1% | 0.34% | +3.7% |
| Q3 2017 | $4,673,000 | – | 334,279 | – | 0.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 1,711,067 | $2,943,000 | 1.70% |
| J.P. Turner & Co Capital Mnagement, LLC | 248,625 | $428,000 | 0.44% |
| Orbimed Advisors | 3,323,000 | $5,716,000 | 0.06% |
| BALYASNY ASSET MANAGEMENT L.P. | 2,004,078 | $3,447,000 | 0.02% |
| WOLVERINE ASSET MANAGEMENT LLC | 5,870 | $1,018,000 | 0.02% |
| SIGNET FINANCIAL MANAGEMENT, LLC | 44,675 | $77,000 | 0.02% |
| SVB WEALTH LLC | 195,000 | $335,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 288,900 | $497,000 | 0.01% |
| J.P. Turner & Co Capital Mnagement, LLC | 153,900 | $8,000 | 0.01% |
| BALYASNY ASSET MANAGEMENT L.P. | 640,400 | $1,101,000 | 0.01% |